AKT1 and cancer: The results showed that the significant enriched pathways of the downregulated DEPs were cytokine–cytokine receptor interaction, PI3K-Akt signaling pathway, proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, and Jak-STAT signaling pathway (Table 4).